![Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología](https://static.elsevier.es/multimedia/03002896/0000005800000010/v2_202302271800/S0300289622003374/v2_202302271800/en/main.assets/gr1.jpeg)
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
![Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14237d6f07c90838ca1277212ca4bae185748743/5-Table1-1.png)
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
![Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41533-020-00205-9/MediaObjects/41533_2020_205_Fig1_HTML.png)
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
![Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X](https://pbs.twimg.com/media/DtzVlWsWwAArrfB.jpg)
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X
![Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213219818300904-gr1.jpg)
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
![Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/99590a94-40e5-47cb-b268-379b1f648d1d/gr2.jpg)
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
![JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations](https://www.mdpi.com/jcm/jcm-11-06623/article_deploy/html/images/jcm-11-06623-g001.png)
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
![Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.2147%2FCOPD.S350167&id=dcop_a_12164092_uf0001_c.jpg)
Full article: A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
![Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12325-021-01646-5/MediaObjects/12325_2021_1646_Fig2_HTML.png)
Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database | Advances in Therapy
American College of Chest Physicians - In a real-world setting, LAMA-LABA- ICS is as effective as LAMA-LABA to prevent COPD exacerbations, but incidence of pneumonia increased with triple therapy initiation: https://hubs.ly/H0pPLQ20 | Facebook
![BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone](https://hardoctor.files.wordpress.com/2023/04/bpco-rischio-di-eventi-cardiovascolari-e-terapia-combinata.png)
BPCO: rischio di eventi cardiovascolari e terapia combinata – HarDoctor News, il Blog di Carlo Cottone
![Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12931-021-01777-x/MediaObjects/12931_2021_1777_Fig6_HTML.png)
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text
![Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/14237d6f07c90838ca1277212ca4bae185748743/3-Figure1-1.png)